Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status  Phase of research How it helps Latest publication
Imdevimab
Emergency use authorization Experimental Antiviral Jan/23/2023
BNT162b1
Potential treatment - clinical evidence Experimental Vaccine Aug/12/2020
NVX-CoV2373
Potential treatment - clinical evidence Experimental Vaccine Apr/07/2021
candidate vaccine (Sanofi + GSK)
Potential treatment - clinical evidence Experimental Vaccine Mar/26/2020
CIGB-325
Potential treatment - clinical evidence Experimental Antiviral Dec/11/2020
Infliximab
Potential treatment - clinical evidence Experimental Antiviral Feb/01/2021
rSIFN-co
Potential treatment - clinical evidence Experimental Antiviral Feb/23/2021
Mesenchymal stem cells
Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022
SinaCurcumin®
Potential treatment - clinical evidence Experimental Antiviral Mar/28/2021
ZF2001
Potential treatment - clinical evidence Experimental Vaccine Mar/24/2021
BBIBP-CorV
Potential treatment - clinical evidence Experimental Vaccine Dec/23/2021
(Recombinant) IL-2
Potential treatment - clinical evidence Experimental Other treatment Jan/18/2021
Menstrual blood-derived stem cells
Potential treatment - clinical evidence Experimental Other treatment Mar/06/2021
Triazavirin
Potential treatment - clinical evidence Experimental Antiviral Sep/08/2020
Xuanfei Baidu decoction
Potential treatment - clinical evidence Experimental Unknown Oct/21/2020
Autologous conditioned serum
Potential treatment - clinical evidence Experimental Other treatment Aug/20/2020
INO-4800
Potential treatment - clinical evidence Experimental Vaccine Dec/23/2020
Inactivated SARS-CoV-2 vaccine
Potential treatment - clinical evidence Experimental Vaccine Nov/09/2020
Canrenone
Potential treatment - clinical evidence Experimental Other treatment Sep/11/2020
LFG316
Potential treatment - clinical evidence Experimental Other treatment Sep/08/2020